These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11797587)

  • 21. National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing.
    Mahmud A; Bennett K; Okechukwu I; Feely J
    Br J Clin Pharmacol; 2007 Nov; 64(5):706-9. PubMed ID: 17555462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 23. [Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation. Results of the BAFTA trial].
    Liakishev AA
    Kardiologiia; 2008; 48(2):68. PubMed ID: 18261012
    [No Abstract]   [Full Text] [Related]  

  • 24. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
    Gallagher AM; Rietbrock S; Plumb J; van Staa TP
    J Thromb Haemost; 2008 Sep; 6(9):1500-6. PubMed ID: 18573187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 26. Atrial fibrillation and mild cognitive impairment: what correlation?
    Puccio D; Novo G; Baiamonte V; Nuccio A; Fazio G; Corrado E; Coppola G; Muratori I; Vernuccio L; Novo S
    Minerva Cardioangiol; 2009 Apr; 57(2):143-50. PubMed ID: 19274024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin?
    Guthmann RA
    Am Fam Physician; 2004 Sep; 70(5):917-8. PubMed ID: 15368730
    [No Abstract]   [Full Text] [Related]  

  • 28. Community-based study of atrial fibrillation and stroke prevention.
    White S; Feely J; O'Neill D
    Ir Med J; 2004 Jan; 97(1):10-2. PubMed ID: 15055913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
    Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 33. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID.
    Kasner SE; Lynn MJ; Chimowitz MI; Frankel MR; Howlett-Smith H; Hertzberg VS; Chaturvedi S; Levine SR; Stern BJ; Benesch CG; Jovin TG; Sila CA; Romano JG;
    Neurology; 2006 Oct; 67(7):1275-8. PubMed ID: 17030766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of antithrombotic therapy in atrial fibrillation.
    Connolly SJ
    G Ital Cardiol; 1994 Mar; 24(3):341-3. PubMed ID: 8063070
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral anticoagulation and stroke in atrial fibrillation.
    Epstein EF; Natarajan I
    N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674042
    [No Abstract]   [Full Text] [Related]  

  • 37. Stroke prevention in atrial fibrillation--pharmacologic strategies.
    Tiyyagura SR; Goldbarg SH; Mehta D
    Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of thrombolitic compications with atrial fibrillation].
    Abuladze G; Jinjolia N; Narsia E; Abashidze R; Kajaia T
    Georgian Med News; 2008 Oct; (163):35-8. PubMed ID: 18997251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.